Apolipoprotein E-ε2 and Alzheimer's disease: Genotype influences pathologic phenotype

Neurology

Volumn 48, Issue 2, 1997, Pages 515-519

  Lippa, Carol F ^a   Smith, T W ^b   Saunders, A M ^c   Hulette, C ^c   Pulaski Salo, D ^b   Roses, A D ^c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E; APOLIPOPROTEIN E3;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; VASCULAR DISEASE; ALLELE; BRAIN; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; ALLELES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEINS E; BRAIN; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; PHENOTYPE;

EID: 0030614668     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.2.515     Document Type: Article

References (38)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high affinity binding to β-amyloid increased frequency of type 4 allele in familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
2. Saunders AM, Strittmatter WJ, Schmechel DE, et al. Association of apolipoprotein E allele∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
3. Saunders AM, Schmader K, Breitner JCS, et al. Apolipoprotein ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993;342:710-711.
4. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-699.
5. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ∈4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34:752-754.
6. Brousseau T, Legrain S, Berr C, Gourlet V, Vidal O, Amouyel P. Confirmation of the ∈4 allele of the apolipoprotein E gene as a major risk factor for late-onset Alzheimer's disease. Neurology 1994;44:342-344.
7. Peacock ML, Fink JK. ApoE allelic association with Alzheimer's disease: independent confirmation using denaturing gradient gel electrophoresis. Neurology 1994;44:339-341.
8. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 1993;261:921-923.
9. Houlden H, Crook R, Duff K, et al. Confirmation that the apolipoprotein E4 allele is associated with late-onset familial Alzheimer's disease. Neurodegeneration 1993;2:283-286.
10. Mak YT, Chiu H, Woo J, et al. Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese. Neurology 1996;46:146-149.
11. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994;125:163-171.
12. Houlden H, Collinge J, Kennedy A, et al. APOE genotype and Alzheimer's disease. Lancet 1993;342:737-738.
13. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late-onset Alzheimer disease. Nat Genet 1994;7:180-184.
14. Talbot CE, Lendon C, Craddock N, Shears S, Morris JC, Goate A. Protection against Alzheimer's disease with apoE ∈2. Lancet 1994;343:1432-1433.
15. Mui S, Briggs M, Chung H, et al. A newly identified polymorphism in the ApoE enhancer (IE1) gene region is associated with Alzheimer's disease and strongly with the ∈4 allele. Neurology 1996;47:196-201.
16. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid peptide deposition as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:9649-9653.
17. West HL, Rebeck W, Hyman BT. Frequency of apolipoprotein E ∈2 allele is diminished in sporadic Alzheimer's disease. Neurosci Lett 1994;175:46-48.
18. Talbot C, Lendon C, Craddock N, Shears S, Morris K, Goate A. Protection against Alzheimer's disease with apoE ∈2. Lancet 1994;343:1432-1433.
19. Chartier-Harlin MC, Parfitt M, Legrain S, et al. Apolipoprotein E ∈4 allele as a major risk factor for sporadic early and late-onset form of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994;3:569-574.
20. Sorbi S, Nacmias B, Forleo P, et al. ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett 1994;177:100-102.
21. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation and genotype risk. Ann Neurol 1995;37:254-259.
22. van Duijn C, de Knijff P, Wehnert A, et al. The apolipoprotein E ∈2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 1995; 37:605-610.
23. Mirra SS, Heyman A, McKeel D, Sumi SM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Neurology 1991;41:479-486.
24. Hixon J, Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhAI. J Lipid Res 1991;31:545-548.
25. Campbell SK, Switzer RC, Martin TL. Alzheimer's plaques and tangles: a controlled and enhanced silver staining method [abstract]. Soc Neurosci Astr 1987;13:678.
26. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of β-protein. N Engl J Med 1995;333:1242-1247.
27. Greenberg SM, Rebeck GW, Vonsattel JPG, Gomez-Isla Hyman BT. Apolipoprotein E ∈4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995;38:354-359.
28. Olichney JM, Hansen LA, Galasko D, et al. The apolipoprotein E ∈4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996;47:190-196.
29. Davignon J, Bouthillier D, Nestruck AC, Sing CF. Apolipoprotein E polymorphism and atherosclerosis: insights from a study of octogenarians. Trans Am Clin Climatol Assoc 1987; 99:100-110.
30. Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 1994;53:429-437.
31. Strittmatter WJ, Weisgraber KH, Huang D, et al. Binding of human apolipoprotein E to βA4 peptide: isoform-specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:8096-8102.
32. Wisniewski T, Golabek A, Matsubara E, Ghiso J, Frangione B. Apolipoprotein E: binding to soluble Alzheimer's amyloid. Biochem Biophys Res Comm 1993;192:359-365.
33. Roses AD. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease [reply]. Ann Neurol 1995;38:969-970.
34. Corder EH, Roses AD. No increased risk of the apolipoprotein E ∈2 allele with early-onset Alzheimer's disease [letter]. Ann Neurol 1996;39:414-415.
35. Hendrie HC, Hall KS, Hui S, et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol 1995;37:118-120.
36. Lippa CF, Saunders AM, Smith TW, et al. Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway. Neurology 1996;46:406-412.
37. Van Broeckhoven C, Backhovens H, Cruts M, et al. APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett 1994; 169:179-180.
38. Lippa CF, Smith TW, Saunders AM, et al. Apolipoprotein E genotype and Lewy body disease. Neurology 1995;45:97-103.